Quick Answer
Emmaus Life Sciences, Inc. reported Total Assets of $21.44 million for fiscal year 2025.
Emmaus Life Sciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $21.44M | -9.2% |
| 2024 | $23.60M | -32.9% |
| 2023 | $35.18M | -27.1% |
| 2022 | $48.23M | -15.0% |
| 2021 | $56.73M | -4.7% |
| 2020 | $59.54M | +0.1% |
| 2019 | $59.46M | +2.3% |
| 2019 | $58.10M | -22.8% |
| 2018 | $75.28M | +1361.2% |
| 2018 | $5.15M | -15.5% |
| 2017 | $6.10M | +1090.4% |
| 2016 | $512.1K | -9.7% |
| 2015 | $567.1K | -57.6% |
| 2014 | $1.34M | -4.7% |
| 2013 | $1.40M | +1019.1% |
| 2012 | $125.3K | -66.1% |
| 2011 | $370.0K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $20.76M | -24.1% | -11.1% |
| June 30, 2025 | $23.34M | -10.0% | +3.9% |
| March 31, 2025 | $22.48M | -23.9% | -4.8% |
| December 31, 2024 | $23.60M | -32.9% | -13.7% |
| September 30, 2024 | $27.34M | -42.4% | +5.4% |
| June 30, 2024 | $25.94M | -48.4% | -12.2% |
| March 31, 2024 | $29.54M | -39.6% | -16.0% |
| December 31, 2023 | $35.18M | -27.1% | -25.9% |
- Emmaus Life Sciences, Inc. showed a decrease of -9.2% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, Emmaus Life Sciences, Inc.’s total assets has grown by 5693.5% (from $370.0 thousand to $21.44 million).
- The most recent figure is from Emmaus Life Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: